Prior research has also established the role of GPER1 in estrogen-related conditions, including female breast and ovarian malignancies [26,27], cervical and endometrial cancers [28,29], male prostate cancer [30,31], gastrointestinal tract cancers [32,33], and melanoma [34]. This evidence concerns the gene GPER1 and endometrial cancer.